NEW YORK (GenomeWeb News) – The National Cancer Institute has started a new effort to help firms that have won Phase II funding under its Small Business Innovation Research program to work their way through the regulatory approval process.
The pilot Regulatory Assistance Program, open to new and recent SBIR and Small Business Technology Transfer grantees, will provide up to 30 hours of time with regulatory consultants to companies developing new medical devices or therapeutics.